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ARTICLE

An ITAM-signaling pathway controls crosspresentation of particulate but not soluble
antigens in dendritic cells
Daniel B. Graham,1 Linda M. Stephenson,1 Siu Kit Lam,1 Karry Brim,1
Hyang Mi Lee,1 Jhoanne Bautista,1 Susan Gilfillan,1 Shreeram Akilesh,1
Keiko Fujikawa,2 and Wojciech Swat1
1Department

Dendritic cells (DC) possess a unique capacity for presenting exogenous antigen on major
histocompatibility class I, a process that is referred to as cross-presentation, which serves a
critical role in microbial and tumor immunity. During cross-presentation, antigens derived
from pathogen-infected or tumor cells are internalized and processed by DCs for presentation
to cytotoxic T lymphocytes (CTLs). We demonstrate that a signaling pathway initiated by the
immunoreceptor tyrosine–based activation motif (ITAM)–containing adaptors DAP12 and
FcR␥ utilizes the Vav family of Rho guanine nucleotide exchange factors (GEFs) for processing
and cross-presentation of particulate, but not soluble, antigens by DCs. Notably, this novel
pathway is crucial for processing and presentation of particulate antigens, such as those
associated with Listeria monocytogenes bacteria, yet it is not required for antigen uptake.
Mechanistically, we provide evidence that in DCs, Vav GEFs are essential to link ITAMdependent receptors with the activation of the NOX2 complex and production of reactive
oxygen species (ROS), which regulate phagosomal pH and processing of particulate antigens for
cross-presentation. Importantly, we show that genetic disruption of the DAP12/FcR␥–Vav pathway leads to antigen presentation defects that are more profound than in DCs lacking NOX2,
suggesting that ITAM signaling also controls cross-presentation in a ROS-independent manner.
CORRESPONDENCE
Wojciech Swat:
swat@wustl.edu
Abbreviations used: GEF, guanine nucleotide exchange factor;
ITAM, immunoreceptor tyrosine–based activation motif;
LM, Listeria monocytogenes; MFI,
mean fluorescence intensity;
ROS, reactive oxygen species.

DCs serve a critical role in microbial and tumor
immunity by presenting exogenous antigens on
MHC I to elicit CTL responses, a process that
is referred to as cross-presentation. Although the
importance of cross-presentation for efficient
priming of CTL responses has been recognized
for >30 yr (1), the signal transduction pathways
that regulate cross-presentation in DCs remain
to be elucidated.
DCs have developed several specialized
mechanisms of antigen processing that promote
cross-presentation. Whereas soluble antigens are
internalized by constitutive macropinocytosis,
uptake of particulate antigens, such as dying
cells and microbes, requires receptor-mediated
phagocytosis. Numerous receptors expressed on
DCs are implicated in phagocytic uptake of
particulates that include complement receptors,
FcRs, and scavenger receptors (2). In this context, the results of our previous studies implicated
The online version of this article contains supplemental material.
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Vav family guanine nucleotide exchange factors
(GEFs) in the uptake of particulates (3). After
antigen uptake, cross-presentation involves the
processing of antigen and loading onto MHC I,
which can proceed via several distinct pathways
(4–7). For example, soluble antigens taken up
by macropinocytosis are thought to enter the
endosomal pathway, and they can be processed
and loaded onto MHC I in a TAP- and proteosome-independent manner, whereas particulate antigens taken up by phagocytosis enter the
phagolysosomal pathway (4, 8). Recent reports
also suggest that fusion of phagosomes with
the ER may be involved in the loading of antigenic peptides onto MHC I in a TAP-dependent
manner (9–13). In addition, phagosome maturation and antigen processing may also be regulated by TLR-mediated pathways (14, 15).
A recent study implicated a role for NOX2
and reactive oxygen species (ROS) production in
antigen processing in the early phagosomal compartment during cross-presentation by DCs (16).

Supplemental Material can be found at:
http://jem.rupress.org/content/suppl/2007/12/05/jem.20071283.DC1.html
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RESULTS
Defective cross-presentation of particulate antigens
by VavNULL dendritic cells
One of the critical functions of DCs is to prime CTL responses by cross-presentation of exogenous antigens, such as
pathogen-infected or dying cells. Given the results of our
previous studies, which implicated Vav family GEFs in the
uptake of particulates (3), we sought to determine if Vav proteins were involved in antigen uptake and/or processing by
DCs. To test the requirement for Vav proteins (Vav1, Vav2,

and Vav3) in cross-presentation of MHC I–associated antigens to CD8 T cells by DCs, we used mice lacking the entire
Vav family (VavNULL) (24). Bone marrow–derived DCs from
wild-type and VavNULL mice were cultured with either OVApeptide (spanning the OT-1 T cell epitope SIINFEKL) or
OVA protein. DCs were then cocultured with purified OT1
TCR-transgenic CD8+ T cells, and OT-1 T cell proliferation was monitored by CFSE dye-dilution assay (Fig. 1 A).
As a control, purified OT1 T cells were incubated with OVApeptide in the absence of any exogenously added DCs, and
no T cell proliferation was observed under these conditions
(unpublished data).
Similar to WT DCs, VavNULL DCs cultured with OVApeptide efficiently induced OT-1 T cell proliferation over a
broad range of peptide concentrations (Fig. 1 B). Consistent
with this observation, VavNULL DCs showed normal morphology and cell surface marker expression, including that of
costimulatory molecules before and after maturation with LPS
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20071283/DC1, and not depicted). Given that VavNULL
DCs were capable of inducing T cell proliferation in response
to exogenously added antigenic peptides, we next examined
whether or not Vav is required for processing and presentation of whole OVA protein. Notably, both WT and VavNULL
DCs presented soluble OVA protein to OT-1 T cells with
the same efficiency (Fig. 1). As a control, OT-1 T cells were
stimulated with OVA protein in the presence of fixed DCs,
and no T cell proliferation was observed at concentrations
inducing maximal proliferation with live DCs (unpublished
data). Collectively, these experiments demonstrate that Vav
proteins are not required for the presentation of peptides or
intracellular processing of soluble protein antigens by the class I
MHC pathway in DCs.
To determine if Vav is required for processing and presentation of particulate antigens to CTLs by DCs, we loaded
WT and VavNULL DCs with latex beads coupled to OVA

Figure 1. Vav is required for cross-presentation of particulate, but not soluble, antigen. (A) WT and VavNULL BMDCs were cultured with CFSElabeled OT-1 T cells and the indicated antigens for 72 h. T cell proliferation was determined by CFSE dye dilution and FACS analysis. (B) T cell proliferation
was determined as in A and plotted as antigen dose versus the percentage of T cells that had undergone at least one division.
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However, the mechanism of NOX2 activation in DCs has not
been elucidated, and which receptors and signaling intermediates regulate ROS production in DCs remains unclear. In this
regard, recent reports indicate that ROS production in neutrophils is largely dependent on immunoreceptor tyrosine–
based activation motif (ITAM)–mediated signaling pathways
triggered by DAP12- and FcR-associated receptors (17, 18).
Thus, similar to ITAM-mediated antigen receptor signaling in
T and B lymphocytes, ITAM signaling in myeloid cells involves phosphorylation of conserved ITAM tyrosine residues
by Src family kinases providing docking sites for the tandem
SH2 domains of Syk family kinases (for review see references
[19, 20]). These observations are notable, as they raise the possibility that ITAM-dependent mechanisms may also be involved
in regulation of ROS production and antigen presentation in
DCs. In this regard, recently published works indicate the importance of Vav in ROS production and oxidative burst in
macrophages and neutrophils (21–23); however, it is not
known if Vav and/or DAP12 and FcR are involved in the
regulation of ROS production, or antigen processing and presentation, in DCs.
We present evidence that Vav GEFs link DAP12 and
FcR ITAM-containing adaptors with antigen processing
and cross-presentation in DCs via a mechanism that is dependent, in part, on Nox2-dependent ROS generation.

Published November 5, 2007
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Selective defects in antigen uptake by VavNULL DCs
Dendritic cells internalize antigens by macropinocytosis and
phagocytosis. Previous studies showed that DCs undergo
constitutive macropinocytosis to sample the environment
and efficiently internalize soluble protein antigens (2, 25, 26).
To determine if Vav GEFs are required in this process, we
tested the efficiency of macropinocytosis in VavNULL DCs.
These experiments showed that both WT and VavNULL DCs
were equally efficient at internalizing 70-kD dextran-FITC
at various time points, indicating that constitutive macropinocytosis in DCs does not require Vav proteins (Fig. 2 A).
Moreover, we observed no differences in endosomal loading
with Dextran-FITC by single-cell imaging (Fig. 2 B).
To examine internalization of particulate antigens, we next
analyzed the ability of VavNULL DCs to phagocytose latex
beads or heat-killed bacteria labeled with fluorescent dyes
at different time points using confocal microscopy and FACSbased assays (Fig. 3, A and B). These experiments revealed
that the kinetics of bead uptake by VavNULL DCs were delayed (Fig. 3 C). During a 15-min incubation with beads,
ⵑ30% fewer VavNULL DCs internalized beads as compared
with WT. However, by 60 min, uptake of beads was indistinguishable between VavNULL and WT DCs (Fig. 3 C). In
contrast, the ability of WT and VavNULL DCs to internalize
bacteria such as heat-killed LM was identical (Fig. 3 D). Thus,
although a delay in bead internalization could conceivably
contribute to defects in presentation of bead-linked OVA antigen by VavNULL DCs, normal intake but defective presentation of LM-OVA indicates that Vav is required for intracellular
processing of physiological particulate antigens.
Critical function of Vav in the regulation of NOX2 and ROS
production in DCs
A recent study implicated a role for NOX2 and ROS production in antigen processing in the early phagosomal compartment
JEM VOL. 204, November 26, 2007

Figure 2. Vav is not required for macropinocytosis of soluble antigen.
(A) BMDCs were cultured with 70 kD FITC-Dextran (FITC-Dex) for the
indicated time points at 4 or 37°C. FITC uptake by macropinocytosis was
determined by FACS. (B) BMDCs were treated as in A and examined for
FITC uptake by single-cell imaging. Bar, 5 m.

during cross-presentation by DCs (16). However, it remains
unclear which signaling pathways regulate NOX2 activation
in DCs during antigen processing and presentation. Previously published work indicated the importance of Vav in ROS
production and oxidative burst in macrophages and neutrophils (21–23), suggesting that Vav may also be required for
the regulation of NOX2 and ROS production by DCs.
To address this issue, we directly compared the generation of
ROS in WT, NOX2-deficient, and VavNULL DCs incubated
with latex beads. In contrast to WT, NOX2-deficient DCs
failed to produce ROS, indicating that NOX2 is the major
source of ROS generated by DCs in these assays (Fig. 4).
Strikingly, VavNULL DCs exhibited defects in ROS production that were comparable in magnitude to NOX2-deficient
DCs (Fig. 4 A). These results suggest that Vav is required for
NOX2 induction and ROS production by DCs undergoing
phagocytosis of latex beads. In addition, we tested the requirement of Vav in ROS production induced by various
adhesion-dependent stimuli (17, 18). In contrast to WT DCs,
which showed robust ROS production, VavNULL DCs failed
to produce any detectable ROS upon adhesion to fibronectin
or stimulation with LPS, peptidoglycan, or zymosan (Fig. 4,
B-E). Importantly, VavNULL, but not NOX2-deficient, DCs
responded to PMA with robust ROS production (Fig. 4 E,
inset, and not depicted). Thus, collectively, these experiments
indicate that although VavNULL DCs express all essential components of the NOX2 complex and can generate ROS in
2891
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protein and examined their ability to elicit proliferation of
OT-1 T cells. In striking contrast to WT DCs, which induced vigorous T cell proliferation, VavNULL DCs loaded
with bead-coupled OVA completely lacked the ability to
induce proliferation of OT-1 T cells (Fig. 1). Importantly,
VavNULL and WT DCs cultured with OT-1 T cells and OVA
beads (or OVA peptide) showed similar levels of expression
of costimulatory molecules, including B7-1 and -2, indicating that their maturation state was similar (Fig. S2).
To examine presentation of a more physiologically relevant form of particulate antigen, we cultured DCs with heatkilled Listeria monocytogenes expressing OVA (LM-OVA) and
monitored OT-1-T cell proliferation. In contrast to WT
DCs, VavNULL DCs lacked the ability to induce OT-1 T cell
responses to bacteria-associated antigens such as LM-OVA
(Fig. 1). Therefore, given that VavNULL DCs could efficiently
present antigenic peptides and soluble protein to naive T cells
(Fig. 1 and not depicted), our results indicate a selective requirement in uptake and/or processing of particulate antigens
by DCs.

Published November 5, 2007

response to phorbol esters, Vav proteins are required for NOX2
activation and ROS production in response to adhesiondependent stimuli. Furthermore, our data also suggest that Vavdependent ROS production is critical for cross-presentation
of particulate antigens.

Figure 4. Vav is required for ROS production in DCs. ROS production in BMDCs was determined with the chemiluminescent substrate lucigenin. Cells were stimulated with 5 l/sample latex beads (A), 1 g/ml
plate-bound fibronectin (Fbn; B), 10 g/ml LPS (C), 10 g/ml peptidoglycan (PGN; D), and 20 g/ml zymosan (Zym; E). (inset) Cells stimulated
with 50 ng/ml PMA for 60–70 min. RLU, relative light units.
2892

Given that VavNULL and NOX2-deficient DCs both failed to
generate detectable levels of ROS in response to adhesionmediated stimuli, we sought to examine the efficiency of
cross-presentation in NOX2-deficient DCs using the same
OT-1 T cell-based assay described in Fig. 1. These experiments showed that, consistent with previous studies (16), the
ability of NOX2-deficient DCs to cross-present bead-linked
OVA was diminished, as indicated by reduced OT-1 T cell
proliferation, whereas NOX2 was not required for the induction of OT-1 T cell responses by DCs pulsed with soluble
antigens such as OVA-peptide or protein (Fig. S3, available
at http://www.jem.org/cgi/content/full/jem.20071283/DC1,
and not depicted). As expected, defective presentation of particulate antigen in NOX2-deficient DCs was not caused by
inefficient uptake of OVA-beads, as we observed no defects
in bead-phagocytosis in these cells (Fig. S4), which is in agreement with a previous study (16). We note, however, that crosspresentation defects of NOX2−/− DCs were relatively mild, as
compared with VavNULL DCs, which showed a complete block
in cross-presentation of particulates. We interpret these results
as indicating that Vav proteins regulate cross-presentation via
both ROS-dependent and -independent mechanisms.
Given the strict requirement for Vav in the generation of
ROS by DCs, we hypothesized that VavNULL DCs, similar to
NOX2-deficient DCs, could exhibit a reduction in phagosomal pH caused by the loss of neutralizing activity of ROS.
To measure phagosomal pH, WT and VavNULL DCs were
loaded with latex beads covalently coupled to pH-sensitive
ITAM SIGNALING CONTROLS CROSS-PRESENTATION | Graham et al.
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Figure 3. Vav is not required for phagocytosis of latex beads or bacteria. (A) BMDCs were stained with FITC anti-CD11b to demarcate the membrane and cultured with latex beads. Cells were then distributed onto slides and analyzed by confocal microscopy. Optical slices through the z plane were
imaged at 2-m increments from the bottom of the cell to the top, and they are portrayed from left to right. DIC images clearly reveal the bead, which is
highly refractive. Bar, 5 m. (B) BMDCs were cultured with Alexa Fluor 647–labeled latex beads and analyzed for phagocytosis by FACS. (C) BMDCs were
cultured with latex beads for the indicated time points and scored for phagocytosis by microscopy. Data represent the mean ± the SD of the percentage
of cells that internalized at least one bead. Scoring was performed in triplicate and accounted for at least 125 cells per condition. (D) BMDCs were cultured with CFSE-labeled LM for the indicated time points at 37°C. The percentage of cells that had internalized at least one bacterium is expressed as the
mean ± the SD of triplicate scoring, which included at least 125 cells per condition.

Published November 5, 2007
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Defective cross-presentation of particulate antigens
by DAP12−/−FcR␥−/− dendritic cells
Previous studies indicated that, in neutrophils, ROS production in response to various adhesion-dependent stimuli requires ITAM-containing DAP12 and FcR adaptors (17, 19).

Given that Vav proteins have been implicated in control of
ITAM-mediated signaling pathways in several hematopoietic
lineages, including T, B, and NK cells (27), we hypothesized
that Vav would link ROS production in DCs to ITAM-dependent signaling by DAP12 and FcR, which is triggered
by integrin receptors in neutrophils (17, 19). Consistent with
such a scenario, we found that Vav was inducibly tyrosine phosphorylated in DCs upon stimulation by adhesion to the integrin
ligand fibrinogen (Fig. 6 A), a process that is critically dependent on the function of DAP12 and FcR ITAMs (17, 19).
To confirm that, under these conditions, tyrosine phosphorylation of Vav was, indeed, dependent on signals emanating
from DAP12 and FcR, we used DCs from mice deficient in
DAP12 and FcR. Strikingly, we found in these experiments
that tyrosine phosphorylation of Vav was drastically diminished in DAP12 and FcR DCs, which is consistent with the
uncoupling of Vav from adhesion-induced signaling pathways
in the absence of DAP12 and FcR (Fig. 6 A). Moreover,
both VavNULL and DAP12 and FcR DCs showed diminished ERK activation in response to integrin-mediated adhesion (Fig. 6 B and not depicted). Thus, it appears that Vav is
involved in transduction of signals that emanate from DAP12
and FcR adaptors in DCs.
Given the recently published work indicating a critical
role for DAP12 and FcR adaptors in NOX2 activation and
ROS production in neutrophils (17), we tested the ability of
DAP12 and FcR DCs to generate ROS in response to multiple adhesion-dependent stimuli, including latex beads, LM,
and LPS (Fig. 6 C). Strikingly, DAP12 and FcR DCs completely lacked the ability to generate ROS under these conditions (Fig. 6 C). We note that the total loss of detectable ROS
production in DAP12 and FcR DCs mirrored the loss of
ROS we observed in VavNULL and NOX2-deficient DCs
(Fig. 4 and not depicted). Thus, taking into consideration that
Vav and NOX2 are critical for cross-presentation of particulate antigens in DCs, these results suggested an intriguing possibility that a DAP12/FcR ITAM-based signaling pathway

Figure 5. Vav controls phagosomal pH and antigen degradation. (A) Phagosomal pH was measured in BMDCs using latex beads coupled with
pH-sensitive FITC and pH-insensitive Alexa Fluor 647. DCs were loaded with beads for 30 min, washed, and cultured for the indicated time points before
analysis by FACS. For analysis, cells that had internalized equal numbers of beads (based on Alexa Fluor 647 MFI) were gated and analyzed for FITC MFI.
Data represent the relative fold change in FITC MFI over time. (B) Antigen degradation in phagosomes was monitored using latex beads covalently coupled to
OVA. DCs were loaded with beads for 30 min, washed, and cultured for the indicated time points. Beads were then recovered by lysing the cells and
stained with anti-OVA antibodies before FACS analysis.
JEM VOL. 204, November 26, 2007
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FITC and pH-insensitive Alexa Fluor 647. After phagocytosis of beads, cells were washed, cultured for an additional
1–4 h, and analyzed by FACS for FITC and Alexa Fluor 647
fluorescence. In these experiments, the relative fluorescence
intensity of FITC versus Alexa Fluor 647 remained constant
in WT DCs, indicating a neutral pH environment of phagocytosed beads; however, phagosomes of VavNULL DCs showed
significantly lower ratios of FITC to Alexa Fluor 647 fluorescence over time, indicating a more acidified environment
in VavNULL phagosomes (Fig. 5 A). Given that the acidic
environment of phagosomes would be predicted to lead
to increased activation of pH-sensitive proteases, such as
cathepsins, we decided to test if VavNULL DCs show more
rapid degradation of particulate antigen than WT DCs. To
this end, we loaded DCs with latex beads covalently coupled
to OVA protein, as described above. After washing, DCs
were cultured for an additional hour before recovering beads
by lysis and quantifying OVA remaining on the beads by
staining with polyclonal OVA-specific antibodies and FACS
analysis. These experiments showed that beads recovered
from VavNULL DCs showed decreased fluorescence intensity,
as compared with beads from WT DCs, indicating diminished OVA content (Fig. 5 B). We interpret these experiments as indicating that Vav is involved in the regulation of
phagosomal pH and antigen degradation. We note, however, that a substantial amount of OVA remained intact in
phagosomes derived from VavNULL DCs. Given the profound
defects in cross-presentation observed in VavNULL DCs, as
compared with NOX2-deficient DCs, it is possible that Vav
also controls cross-presentation by mechanisms distinct from
ROS production.

Published November 5, 2007

may control this process. To test this hypothesis, we examined
the ability of DAP12 and FcR DCs to cross-present antigens
using OT-1 T cell-based assays. Remarkably, we found that
similar to VavNULL DCs, DAP12 and FcR DCs could efficiently present soluble OVA peptide and OVA protein to
OT-1 T cells, yet they completely failed to present OVA coupled to beads or expressed in LM (LM-OVA; Fig. 7, A and B).
Collectively, our data implicate a DAP12- and FcR-dependent pathway involving Vav GEFs as critical for NOX2 activation and cross-presentation of particulate antigens in DCs.
DISCUSSION
In this study, we identify an ITAM-mediated signaling pathway that is critically dependent on DAP12 and FcR adaptors
and Vav GEFs that controls ROS production and crosspresentation of particulate antigens by DCs. Although the
importance of cross-presentation for microbial and tumor
immunity has been appreciated since the late 1970s (1), the
exact mechanism by which DCs process exogenous antigens
for cross-presentation on MHCI to CTLs remains controversial, and little is known about signal transduction pathways
that regulate this process. We show that in DCs, Vav GEFs
link ITAM-dependent receptors with the processing of particulate antigens for cross-presentation, although the identities
of the cell surface receptors associated with DAP12 and FcR
that regulate this process remain to be elucidated. In addition,
our results highlight a differential requirement for ITAM
signaling, Vav, and ROS production in cross-presentation of
particulate versus soluble antigens.
2894

Uptake of soluble antigens by macropinocytosis has been
examined in DCs expressing dominant-negative forms of the
Rho family GTPases Rac and Cdc42, both of which were
implicated in macropinocytosis (25, 26); however, Rac1/2deficient DCs have not been examined for macropinocytic
activity (28). Notably, Vav has been implicated in activation
of both Rac and Cdc42 by GTP exchange (29), although we
find that Vav is not required for macropinocytosis in DCs.
Consistent with this observation, Vav is also dispensable for
cross-presentation of soluble antigen.
In contrast to soluble antigen, the uptake of particulate
antigens, such as dying cells and microbes, requires receptormediated phagocytosis. Numerous receptors expressed on
DCs can mediate phagocytosis, including complement receptors (CRs), FcRs, and scavenger receptors (2). Previously
published studies implicated Vav proteins in regulating phagocytosis downstream of CRs and FcRs in macrophages and
neutrophils, respectively (3, 22, 30). Consistent with a role
for Vav in phagocytosis, we observed a moderate delay in
the kinetics of latex bead-uptake by VavNULL DCs, although it is not clear which receptor pathways may be involved in this process. In contrast, phagocytosis of bacteria was
unaffected in the absence of Vav, which is consistent with
our previously published work (21). Importantly, LM-OVA
was efficiently phagocytosed by VavNULL DCs, yet it was
not processed and presented to OT-1 T cells.
After antigen uptake, cross-presentation involves processing of antigen and loading onto MHC I by several distinct
pathways (4, 6, 7). Although the precise mechanisms still
ITAM SIGNALING CONTROLS CROSS-PRESENTATION | Graham et al.
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Figure 6. Adhesion-dependent Vav phosphorylation and ROS production in DCs requires DAP12 and FcR. (A) WT and DAP12 and FcR (DF)
BMDCs were stimulated on fibrinogen-coated plates (150 g/ml) and lysed at the indicated time points. Vav was immunoprecipitated from the lysates,
resolved by SDS-PAGE, and detected by Western blot with anti–phospho-tyrosine antibody. Blots were subsequently stripped and reprobed with anti-Vav
antibody to demonstrate equal protein loading. (B) Alternatively, whole-cell lysates were blotted for phospho-ERK, stripped, and reprobed for total ERK.
(C) ROS production in WT and DF BMDCs was determined with the chemiluminescent substrate lucigenin. Cells were stimulated with latex beads, LM, or
LPS (10 g/ml). RLU, relative light units.

Published November 5, 2007
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remain controversial, it is thought that the mode of antigen
uptake dictates the pathway by which antigen is processed.
Specifically, soluble antigen taken up by macropinocytosis
enters the endosomal pathway and can be processed and
loaded onto MHC I in a TAP- and proteosome-independent
manner (4, 8). Given that VavNULL DCs show no defects in
uptake or processing of soluble antigen, Vav appears to be
dispensable for endosomal processing of antigen. In contrast,
Vav appears to be strictly required for cross-presentation of
particulate antigens, which are taken up by phagocytosis and
enter the phagolysosomal pathway (4).
During the initial phase of antigen processing in the DC
phagosome, NOX2-derived ROS were recently shown to
regulate phagosomal pH (16). The production of ROS by
NOX2 coincides with phagocytosis and consumes protons
in the process, thus neutralizing the phagosome. Upon phagosome neutralization, pH-sensitive proteases are partially inactivated, thus limiting the extent to which protein antigens
are initially degraded. Consequently, potential T cell epitopes are preserved for further processing by the proteosomes
upon transport out of phagosomes (8). Our data indicate that
ROS production during antigen processing is regulated by
ITAM signals propagated through Vav proteins, although
this ITAM pathway may also regulate a ROS-independent
mechanism of antigen processing. In addition, this pathway
may also be required for efficient presentation of particulate
antigens to MHCII-restricted T cells, as VavNULL DCs were
defective in presentation of bead-linked OVA to OT-2 T
cells (Fig. S5, available at http://www.jem.org/cgi/content/
full/jem.20071283/DC1), and NOX2-deficient DCs were
also inefficient at presenting antigen to CD4 T cells (16).
Collectively, these data are consistent with the model in which
ROS production is needed to prevent acidification and antigen
degradation in the phagosomes.
Recent evidence suggests that fusion of phagosomes with
the ER may promote loading of antigenic peptides onto
JEM VOL. 204, November 26, 2007

MHC I in a TAP-dependent manner (9–12), whereas TLRmediated pathways may also be involved in the regulation of
phagosome maturation (14, 15). Our data do not directly address a potential role for Vav in later stages of antigen processing, such as in phagosome maturation and/or trafficking,
although Vav proteins may very well participate in these
processes. Nevertheless, our data clearly identify the Vav
family as a critical regulator of ROS production and crosspresentation in DCs.
In addition to implicating Vav in cross-presentation by
dendritic cells, our data indicate that signals generated by
ITAM-containing adaptors DAP12 and FcR regulate Vav,
and are themselves required for cross-presentation. Although
the identities of the cell surface receptors associated with
DAP12 and FcR that regulate cross-presentation are unknown, one candidate is the integrin family. Recent reports
indicated that adhesion-mediated integrin signaling controls
myeloid cell activation (17, 18). Thus, neutrophils deficient
in DAP12 and FcR exhibit widespread defects in adhesiondependent ROS production (17). Similar to these findings
in neutrophils, we report that DCs from DAP12 and FcR
mice exhibit defects in ROS production induced by adhesion or phagocytosis. Thus, although DAP12 and FcR are
clearly not essential for phagocytosis of latex beads or LM,
together they are critically required for the induction of ROS
production by these stimuli. These data indicate that a DAP12/
FcR-dependent pathway is activated during phagocytosis,
even though it is not required for phagocytosis itself.
Based on our findings, a model can be proposed in which
an integrin and ITAM-mediated pathway, in cooperation
with additional DAP12 and FcR-associated receptors en
ables cross-presentation of particulates in DCs. Among the
candidates are TREMs and SIRPs, which associate with
DAP12 (31), and Fc receptors, which associate with FcR,
although there are likely to be more ITAM-associated receptors yet to be identified in DCs. It is difficult to know which of
2895
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Figure 7. DAP12 and FcR are required for cross-presentation of particulate antigens. (A) CFSE-labeled OT-1 T cells were cultured with WT and
DAP12−/−FcR−/− (DF) BMDCs, along with the indicated antigens. Cells were stimulated for 3 d before analysis of T cell proliferation by CFSE dye dilution and
FACS. (B) T cell proliferation was determined as in Fig. 6 B and plotted as antigen dose versus the percentage of T cells that had undergone at least one division.

Published November 5, 2007

these receptors may be involved in cross-presentation of various
particulate antigens. In addition, the ligands for DAP12associated receptors like the TREMs are not known. It is
possible that these ligands initiate DAP12 signals that regulate antigen presentation; however, such a model is yet to
be formally proven. Although we observed that DAP12 is
not required for cross-presentation of OVA beads to OT-1 T
cells (Fig. S6, available at http://www.jem.org/cgi/content/
full/jem.20071283/DC1), additional ITAM-containing adaptors,
such as FcR, may compensate in the absence of DAP12.
Although further investigation is required to identify the precise
receptors involved in regulating cross-presentation, the data
presented herein clearly indicate that signaling through
a Vav-dependent ITAM pathway is critical for the regulation
of cross-presentation.
Mice. Mice genetically deficient in Vav1, Vav2, and Vav3 (VavNull) have
been previously described (24). NOX2-deficient mice were purchased from
The Jackson Laboratory. OT-1 and -2 mice were a gift from H. Virgin
(Washington University, St. Louis, MO). Mice genetically deficient in
DAP12 and FcR were a gift from M. Colonna (Washington University,
St. Louis, MO). All animal work was performed in accordance with the guidelines of, and was approved by, the Animal Studies Committee of Washington
University School of Medicine.
Antibodies and flow cytometry. The following antibody conjugates were
used (all from BD Biosciences): APC anti-CD8 (53–6.7), FITC anti-CD11b,
PE anti-CDllc (HL3), FITC anti-B7.1 (16-10A1), FITC anti-B7.2 (GL1),
FITC anti-CD40 (3/23), and FITC anti-I-Ab. All samples were analyzed on a
FACSCalibur flow cytometer (Becton Dickinson) with FlowJo software.
Reagents. Synthetic OT-1 peptide (SIINFEKL) and OT-2 peptide (ISQAVHAAHAEINEAGR) were gifts from P. Allen (Washington University,
St. Louis, MO). Purified OVA protein was obtained from Thermo Fisher
Scientific. 10 mg/ml OVA was passively adsorbed to 5-m sulfated latex beads
(Invitrogen) at 37°C for at least 2 h before a thorough washing in PBS. The
final concentration of beads was 7.5 × 105/l. Alternatively, 10 mg/ml
OVA was covalently coupled to 3-m latex amino beads (Polysciences) following the manufacturer’s recommendation. LM expressing OVA was a gift
from D. White (Washington University, St. Louis, MO), and it was heat
killed at 80°C for 2 h. Stock LM was 5.7 × 109 CFU/ml. Amino beads were
also covalently coupled with FITC and Alexa Fluor 647 succinimidyl ester
(Invitrogen) in bicarbonate buffer (pH 9.0), as recommended by the manufacturer. The final concentration of labeled beads was 2.63% vol/vol.
Dendritic cell cultures. Bone marrow was harvested from the femurs and
tibias of mice and cultured in complete DME containing 10% low endotoxin FBS (HyClone) and 2% mouse GM-CSF conditioned media derived
from TOPO cells. Cultures were maintained for 7–10 d and analyzed for
CD11c expression by FACS before use in experiments. Alternatively, fresh
DCs were purified from splenocytes by positive selection using CD11c
MACS beads (Miltenyi Biotec).
In vitro antigen presentation. T cells were purified from OT-1 or -2
spleen and lymph nodes by two rounds of negative selection using MACS
columns (Miltenyi Biotec) or one round of negative selection followed by
one round of positive selection on MACS columns. Purified T cells were
labeled with CFSE (Vybrant CFDA SE cell tracer kit; Invitrogen) according
to the manufacturer’s recommendation. T cells (105 cells/well) were then
cultured with dendritic cells (2 × 104/well) and antigen for 3 d in 96-well
round bottom plates before analysis of CFSE dye dilution by FACS.
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Phagocytosis assays. Dendritic cells (2 × 105 cells/250 l) were cultured
with 2 l FITC/Alexa Fluor 647 beads (stock solution 2.63% vol/vol). Cells
were washed three times in PBS and analyzed by FACS. Alternatively, dendritic cells (4 × 105 cells/200 l) were stained with FITC anti-CD11b for
15 min at 4°C, washed in PBS, resuspended in 200 l DME, and mixed
with the indicated volume of 5-m sulfated latex beads (stock solution 7.5 ×
105beads/l). Cells were washed three times in PBS, distributed onto
poly-l-lysine–coated slides, and fixed in 4% paraformaldehyde before imaging
by confocal microscopy. Cells were visualized on a confocal microscope
equipped with LSM image analysis software (Carl Zeiss, Inc.). Images were
acquired using a 60× objective lens with a 10× ocular lens. Image processing
was performed in Photoshop CS. Phagocytosis of LM was performed similarly.
Dendritic cells (6 × 105 cells/200 l) were cultured with LM (1 l of stock)
that had been labeled with CFSE, as described in In vitro antigen presentation
for T cells. Cells were incubated at 37°C for the indicated time points, washed
three times in PBS, distributed onto poly-l-lysine–coated slides, fixed in 4%
paraformaldehyde, and imaged by fluorescence microscopy.
Oxidative burst assays. Dendritic cells were washed in PBS and resuspended in HBSS supplemented with 12.3 g/ml MgSO4 and 7.2 g/ml
Ca2Cl at a concentration of 2.5–5 × 105 cells/ml. Lucigenin (Invitrogen) was
added to the cells to achieve a final concentration of 150 M, and cells were
distributed into 1-ml aliquots in 5-ml polystyrene luminometer tubes coated
with or without 1 g/ml of fibronectin (Sigma-Aldrich). Baseline luminescence was measured in each sample for 10 s in an OptocompII luminometer
(MGM Instruments, Inc.). Immediately after the baseline reading, cells were
stimulated with LPS, PMA, zymosan, or peptidoglycan (all from SigmaAldrich). Subsequently, luminescence was measured in each sample at the
indicated time points. Luminescence is expressed as relative light units detected over 10 s.
Phagosomal pH measurement. Dendritic cells (4 × 105/200  l DME)
were loaded with FITC/Alexa Fluor 647 beads (1  l) for 30 min at 37°C,
washed, resuspended in 500 l DME, and cultured for the indicated time
points. Cells were then stained with PE-anti-CD11c and analyzed by FACS.
For analysis, FITC fluorescence was measured on a linear scale in CD11c+
cells that had internalized equal numbers of beads, as determined by Alexa
Fluor 647 flourescence intensity. Relative FITC intensity was calculated
based on changes in FITC mean fluorescence intensity (MFI) over the indicated time points.
Antigen degradation. Dendritic cells (4 × 105/200 l DME) were loaded
with OVA-coupled beads (1 l) for 30 min at 37°C, washed, resuspended in
500 l DME, and cultured for the indicated time points. Cells were then
stained with biotinylated anti-OVA rabbit serum (Abcam), followed by
APC-streptavidin (Invitrogen). Cells were washed and subsequently lysed in
1% TX-100 in PBS containing complete protease inhibitor tablets (Boehringer), followed by filtering through nylon mesh. The recovered beads
were then stained with biotinylated anti-OVA rabbit serum, followed by
PE-streptavidin (BD Biosciences). Beads were then analyzed by FACS. For
analysis, PE intensity was evaluated on only the beads that had been internalized (APC negative).
Biochemistry. Dendritic cells (12 × 106 cells/ml in DME) were stimulated
for the indicated time points on 6-well plates coated with 150 g/ml of sheep
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Macropinocytosis assays. Dendritic cells (5 × 105/ml) were cultured with
70 kD FITC Dextran (Invitrogen) at a final concentration of 1 mg/ml in
complete DME. Cells were incubated at 37°C or 4°C for the indicated time
points, washed three times in PBS, and analyzed by FACS for FITC intake.
Alternatively, cells were allowed to adhere to poly-l-lysine-coated slides,
fixed in 4% paraformaldehyde, and visualized by fluorescence microscopy.
Cells were visualized on a fluorescence microscope (E400; Nikon). Images
were acquired using a 60× objective lens with a 10× ocular lens. Image processing was performed in Photoshop CS (Adobe).
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fibrinogen (Sigma-Aldrich) and primed with 50 ng/ml of mouse TNF-
(Peprotech). Cells were lysed for 5 min at 4°C on ice with lysis buffer (1%
TX-100, 0.15 M NaCl, and 25 mM Hepes, pH 7.4). Whole-cell lysates
were resolved by PAGE, transferred to PVDF membranes (Millipore), and
Western blotted with mouse anti–phospho-ERK (Cell Signaling Technology). Blots were subsequently stripped and reprobed with rabbit anti-ERK2
antiserum (Santa Cruz Biotechnology, Inc.). Alternatively, Vav was immunoprecipitated from clarified lysates using 3 g rabbit anti-Vav (Santa Cruz Biotechnology, Inc.) coupled to protein A/G–Sepharose beads (Thermo Fisher
Scientific). After immunoprecipitation for 16 h at 4°C, beads were washed
twice in lysis buffer, eluted with sample buffer, and resolved by SDS-PAGE.
Proteins were then transferred from the gel to PVDF membranes and blotted
with anti-phosphotyrosine (clone 4G10; Millipore). Membranes were subsequently stripped and reprobed with mouse anti-Vav (CHEMICON
International, Inc.). Primary antibodies were detected with HRP-coupled anti–
rabbit IgG (GE Healthcare) or HRP-coupled anti–mouse IgG (Invitrogen)
and ECL chemiluminescent substrate (GE Healthcare).
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